Table 1 Demographic data
| Characteristic |
Group TPVB n = 28 |
Group TAP n = 30 |
Group LAI n = 30 | P |
|---|---|---|---|---|
| Male, n (%) | 13 (46.4) | 12 (40) | 13 (43.3%) | 0.56 |
| Age (years) | 43.0 ± 12.6 | 43.3 ± 12.7 | 41.2 ± 12.6 | 0.94 |
| Body weight (kg) | 57.1 ± 10.3 | 57.6 ± 8.9 | 60.2 ± 11.0 | 0.88 |
| BMI | 21.5 ± 3.1 | 21.5 ± 2.8 | 22.0 ± 1.4 | 0.91 |
| ASA physical status: III/IV | 25 (89.3)/3 (10.7) | 24 (80)/6 (20) | 25 (83.3)/5 (16.7) | 0.62 |
| Renal hypertension | 22 (78.6) | 25 (83.3) | 26 (86.7) | 0.71 |
| Pulmonary infection or COPD | 2 (7.1) | 4 (13.3) | 5 (16.7) | 0.54 |
| Cardiac insufficiency (NYHA classic: grade III/IV) | 5 (17.9) | 7 (23.3) | 6 (20) | 0.87 |
| Causes of chronic renal insufficiency | 0.72 | |||
| Chronic nephritis | 4 (14.3) | 7 (23.3) | 8 (26.7) | |
| Hypertension | 6 (21.4) | 7 (23.3) | 9 (30.0) | |
| Diabetic nephropathy | 2 (7.1) | 3 (10.0) | 1 (3.3) | |
| Obstructive kidney disease | 2 (7.1) | 1 (3.3) | 0 (0) | |
| Unknown | 10 (35.7) | 10 (33.3) | 11 (36.7) | |
| Others | 4 (14.3)* | 2 (6.7)# | 1 (3.3)+ | |